Notifications
Clear all
Topic starter 14/01/2022 5:24 pm
Hello, everyone! What do you think about controversial approval of Aduhelm (Aducanumab) from Biogen Inc.? It may sound promising, but the panel of outside experts on the FDA's Peripheral and Central Nervous System Advisory Committee suggested not to approve the drug...